[ad_1]
In the United States, the population will be distributed between 85 and 100 million. doses of the vaccine and the remaining 15-25 million doses of the vaccine will be administered to other countries, the company noted.
Moderna has also confirmed that it expects to produce 20 million units in the United States by the end of this year. vaccine dose.
The company has been preparing its supply chain and production in the United States for several months in preparation for the planned approval of the vaccine by the United States Food and Drug Administration (FDA).
The vaccine, which is not intended for the United States, will be manufactured in Switzerland.
US officials said they plan to distribute $ 40 million by the end of the year. doses of vaccines, including those developed by Pfizer and BioNTech.
That would mean 20 million will be vaccinated by the end of this year. people because two doses of the vaccine are needed per person.
The FDA Advisory Committee will consider approving the Moderna vaccine on December 17.
Meanwhile, an FDA meeting on the Pfizer-BioNTech vaccine, approved by the UK on Wednesday, will take place on December 10.
[ad_2]
